Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

London pharmacist gets second FtP warning for anti-Semitic remarks made at 2017 rally

The General Pharmaceutical Council's Fitness-to-Practise (FtP) committee has reversed its earlier decision ruling that a London pharmacist's statement, attributing the Grenfell tragedy to "Zionist supporters of the Tory party," amounted to the propagation of anti-Semitic tropes.

In an initial 2020 hearing, the FtP committee found that a set of remarks delivered by Nazim Hussain Ali, Managing Partner of Chelsea Pharmacy Medical Clinic, through a megaphone to a crowd assembled at a Palestinian rights rally in central London in 2017 were deemed "grossly offensive," but not classified as anti-Semitic.


Ali admitted his comments were offensive, but he was cleared of accusations of antisemitism and received a first warning on November 5, 2020.

However, the High Court overturned this decision in June 2021 following an appeal by the Professional Standards Authority as the Judge found evidence of a "serious procedural or other irregularity" in the FtP committee's decision and instructed the GPhC to reopen the case.

Later, the GPhC concluded that the Grenfell events were not linked to Zionism, which involves the development and protection of the State of Israel. Therefore, using the term Zionism in this context would be perceived by a 'reasonable person' as an instance of the anti-Semitic trope.

In a recent hearing from August 29-31, FtP committee determined that two of Ali's statements, out of four submitted for consideration, were indeed anti-Semitic.

  • “Any Zionist, any Jew coming into your centre supporting Israel, any Jew coming into your centre who is a Zionist. Any Jew coming into your centre who is a member for the Board of Deputies, is not a Rabbi, he’s an imposter.”
  • “They are responsible for the murder of the people in Grenfell. The Zionist supporters of the Tory Party.”

The committee found that Ali's remarks constituted "serious misconduct" and a violation of a fundamental professional principle, which dictates that pharmacists must consistently exhibit appropriate behaviour.

'Adhere to pharmacy profession standards' 

In the repeat hearing, Ali received a formal warning, with no additional conditions on his license -- a parallel outcome to the initial 2020 FtP hearing. Taking into account factors including the spontaneous nature of his remarks, the committee deemed a suspension order to be disproportionate.

“The registrant, for all the reasons set out in the Committee’s decision, is hereby given a Warning that his future behaviour and comments that he makes must at all times avoid undermining the reputation of the profession, or the reputation of the regulator and must uphold the required standards of the pharmacy profession,” the FtP warning reads.

“He is reminded in particular that ‘behaving professionally is not limited to the working day, or face to face interactions. The privilege of being a pharmacist and the importance of maintaining confidence in the profession calls for appropriate behaviour at all time,” it added.

However, the Board of Deputies of British Jews strongly condemned the decision, with Amanda Bowman, one of its vice presidents, expressing 'deep concern' about the outcome.

“The Board of Deputies is steadfast in its work to combat hate speech and antisemitism in all parts of society including in the pharmaceutical profession,” Bowman said in a statement. “We believe that this case raises important questions about the standards and values upheld by the GPhC and its Fitness to Practise Committee.”

More For You

NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less